| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | histone H3K4 methyltransferase activity | 9.56e-08 | 20 | 118 | 5 | GO:0042800 | |
| GeneOntologyMolecularFunction | histone H3K4 trimethyltransferase activity | 2.37e-07 | 10 | 118 | 4 | GO:0140999 | |
| GeneOntologyMolecularFunction | dinitrosyl-iron complex binding | 1.99e-06 | 5 | 118 | 3 | GO:0035731 | |
| GeneOntologyMolecularFunction | histone H3 methyltransferase activity | 5.98e-06 | 44 | 118 | 5 | GO:0140938 | |
| GeneOntologyMolecularFunction | steroid delta-isomerase activity | 6.92e-06 | 7 | 118 | 3 | GO:0004769 | |
| GeneOntologyMolecularFunction | recombination hotspot binding | 3.46e-05 | 2 | 118 | 2 | GO:0010844 | |
| GeneOntologyMolecularFunction | protein-lysine N-methyltransferase activity | 5.13e-05 | 68 | 118 | 5 | GO:0016279 | |
| GeneOntologyMolecularFunction | lysine N-methyltransferase activity | 5.50e-05 | 69 | 118 | 5 | GO:0016278 | |
| GeneOntologyMolecularFunction | histone H3K36 methyltransferase activity | 5.51e-05 | 13 | 118 | 3 | GO:0046975 | |
| GeneOntologyMolecularFunction | histone methyltransferase activity | 6.31e-05 | 71 | 118 | 5 | GO:0042054 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | MYLK ANK2 MAP7D3 MAP4 SYNM MYH7B PARVB FTCD NEB SHANK3 LMOD3 RAB11FIP5 AATF DIAPH3 KIF18B TNS1 EPB41 FRMD5 | 7.86e-05 | 1099 | 118 | 18 | GO:0008092 |
| GeneOntologyMolecularFunction | metal cluster binding | 1.33e-04 | 83 | 118 | 5 | GO:0051540 | |
| GeneOntologyMolecularFunction | glutathione binding | 1.54e-04 | 18 | 118 | 3 | GO:0043295 | |
| GeneOntologyMolecularFunction | intramolecular oxidoreductase activity, transposing C=C bonds | 1.82e-04 | 19 | 118 | 3 | GO:0016863 | |
| GeneOntologyMolecularFunction | oligopeptide binding | 2.13e-04 | 20 | 118 | 3 | GO:1900750 | |
| GeneOntologyMolecularFunction | protein methyltransferase activity | 3.65e-04 | 103 | 118 | 5 | GO:0008276 | |
| GeneOntologyMolecularFunction | transferase activity, transferring one-carbon groups | 3.74e-04 | 224 | 118 | 7 | GO:0016741 | |
| GeneOntologyMolecularFunction | N-methyltransferase activity | 3.99e-04 | 105 | 118 | 5 | GO:0008170 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity | 5.11e-04 | 6 | 118 | 2 | GO:0043813 | |
| GeneOntologyMolecularFunction | glutathione peroxidase activity | 5.92e-04 | 28 | 118 | 3 | GO:0004602 | |
| GeneOntologyMolecularFunction | glutathione transferase activity | 6.57e-04 | 29 | 118 | 3 | GO:0004364 | |
| GeneOntologyMolecularFunction | inositol-1,4,5-trisphosphate 5-phosphatase activity | 9.47e-04 | 8 | 118 | 2 | GO:0052658 | |
| GeneOntologyMolecularFunction | histone H3K4 monomethyltransferase activity | 9.47e-04 | 8 | 118 | 2 | GO:0140945 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity | 1.51e-03 | 10 | 118 | 2 | GO:0004439 | |
| GeneOntologyMolecularFunction | phosphatidylinositol phosphate 4-phosphatase activity | 1.51e-03 | 10 | 118 | 2 | GO:0034596 | |
| GeneOntologyMolecularFunction | RNA polymerase II complex binding | 1.57e-03 | 39 | 118 | 3 | GO:0000993 | |
| GeneOntologyMolecularFunction | methyltransferase activity | 1.68e-03 | 213 | 118 | 6 | GO:0008168 | |
| GeneOntologyMolecularFunction | actin binding | 2.17e-03 | 479 | 118 | 9 | GO:0003779 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-4,5-bisphosphate phosphatase activity | 2.20e-03 | 12 | 118 | 2 | GO:0106019 | |
| GeneOntologyMolecularFunction | RNA polymerase core enzyme binding | 2.38e-03 | 45 | 118 | 3 | GO:0043175 | |
| GeneOntologyMolecularFunction | phosphatidylinositol phosphate 5-phosphatase activity | 2.59e-03 | 13 | 118 | 2 | GO:0034595 | |
| GeneOntologyMolecularFunction | carboxylic acid binding | 2.99e-03 | 239 | 118 | 6 | GO:0031406 | |
| GeneOntologyMolecularFunction | inositol trisphosphate phosphatase activity | 3.01e-03 | 14 | 118 | 2 | GO:0046030 | |
| GeneOntologyMolecularFunction | S-adenosylmethionine-dependent methyltransferase activity | 3.58e-03 | 172 | 118 | 5 | GO:0008757 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-3,5-bisphosphate phosphatase activity | 3.94e-03 | 16 | 118 | 2 | GO:0106018 | |
| GeneOntologyMolecularFunction | organic acid binding | 4.02e-03 | 254 | 118 | 6 | GO:0043177 | |
| Domain | SET | 3.85e-07 | 46 | 116 | 6 | SM00317 | |
| Domain | SET_dom | 6.41e-07 | 50 | 116 | 6 | IPR001214 | |
| Domain | SET | 6.41e-07 | 50 | 116 | 6 | PS50280 | |
| Domain | GST_alpha | 2.31e-06 | 5 | 116 | 3 | IPR003080 | |
| Domain | SET | 5.31e-06 | 41 | 116 | 5 | PF00856 | |
| Domain | GST_N | 3.30e-04 | 22 | 116 | 3 | PF02798 | |
| Domain | GST_NTER | 3.30e-04 | 22 | 116 | 3 | PS50404 | |
| Domain | GST_C | 5.47e-04 | 26 | 116 | 3 | IPR004046 | |
| Domain | GST_C | 5.47e-04 | 26 | 116 | 3 | PF00043 | |
| Domain | Glutathione_S-Trfase_N | 6.12e-04 | 27 | 116 | 3 | IPR004045 | |
| Domain | SSXRD | 1.04e-03 | 8 | 116 | 2 | PF09514 | |
| Domain | SSXRD_motif | 1.04e-03 | 8 | 116 | 2 | IPR019041 | |
| Domain | GST_CTER | 1.21e-03 | 34 | 116 | 3 | PS50405 | |
| Domain | IPPc | 1.67e-03 | 10 | 116 | 2 | IPR000300 | |
| Domain | IPPc | 1.67e-03 | 10 | 116 | 2 | SM00128 | |
| Domain | GST_C_3 | 1.67e-03 | 10 | 116 | 2 | PF14497 | |
| Domain | Glutathione-S-Trfase_C-like | 1.81e-03 | 39 | 116 | 3 | IPR010987 | |
| Domain | - | 1.81e-03 | 39 | 116 | 3 | 1.20.1050.10 | |
| Domain | KRAB_RELATED | 2.03e-03 | 11 | 116 | 2 | PS50806 | |
| Domain | Rap_GAP_dom | 2.03e-03 | 11 | 116 | 2 | IPR000331 | |
| Domain | RAPGAP | 2.03e-03 | 11 | 116 | 2 | PS50085 | |
| Domain | FA | 2.85e-03 | 13 | 116 | 2 | PF08736 | |
| Domain | Krueppel-associated_box-rel | 2.85e-03 | 13 | 116 | 2 | IPR003655 | |
| Domain | FERM-adjacent | 2.85e-03 | 13 | 116 | 2 | IPR014847 | |
| Domain | FA | 2.85e-03 | 13 | 116 | 2 | SM01195 | |
| Domain | Post-SET_dom | 4.34e-03 | 16 | 116 | 2 | IPR003616 | |
| Domain | PostSET | 4.34e-03 | 16 | 116 | 2 | SM00508 | |
| Domain | POST_SET | 4.34e-03 | 16 | 116 | 2 | PS50868 | |
| Domain | HMG_box | 4.36e-03 | 53 | 116 | 3 | PF00505 | |
| Domain | HMG_BOX_2 | 4.60e-03 | 54 | 116 | 3 | PS50118 | |
| Domain | HMG | 4.60e-03 | 54 | 116 | 3 | SM00398 | |
| Domain | - | 4.84e-03 | 55 | 116 | 3 | 1.10.30.10 | |
| Domain | Carb_anhydrase | 4.89e-03 | 17 | 116 | 2 | PF00194 | |
| Domain | Carb_anhydrase | 4.89e-03 | 17 | 116 | 2 | SM01057 | |
| Domain | - | 4.89e-03 | 17 | 116 | 2 | 3.10.200.10 | |
| Domain | ALPHA_CA_2 | 4.89e-03 | 17 | 116 | 2 | PS51144 | |
| Domain | Carbonic_anhydrase_a | 4.89e-03 | 17 | 116 | 2 | IPR001148 | |
| Domain | PTPc_motif | 5.89e-03 | 59 | 116 | 3 | SM00404 | |
| Domain | Tyr_Pase_cat | 5.89e-03 | 59 | 116 | 3 | IPR003595 | |
| Pathway | WP_TRANSCRIPTIONAL_ACTIVATION_BY_NFE2L2_IN_RESPONSE_TO_PHYTOCHEMICALS | 1.40e-04 | 17 | 86 | 3 | MM15891 | |
| Pathway | REACTOME_PKMTS_METHYLATE_HISTONE_LYSINES | 1.73e-04 | 46 | 86 | 4 | MM14933 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_DCE_TO_DNA_ADDUCTS | 1.98e-04 | 19 | 86 | 3 | M47809 | |
| Pathway | REACTOME_HEME_DEGRADATION | 2.32e-04 | 20 | 86 | 3 | MM14721 | |
| Pathway | BIOCARTA_ARENRF2_PATHWAY | 3.10e-04 | 22 | 86 | 3 | MM1449 | |
| Pathway | WP_ESTROGEN_METABOLISM | 3.10e-04 | 22 | 86 | 3 | MM15888 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_TCDD_TO_AHR_SIGNALING_PATHWAY | 3.55e-04 | 23 | 86 | 3 | M47806 | |
| Pathway | KEGG_MEDICUS_REFERENCE_KEAP1_NRF2_SIGNALING_PATHWAY | 4.04e-04 | 24 | 86 | 3 | M47487 | |
| Pathway | WP_GLUTATHIONE_METABOLISM | 5.77e-04 | 27 | 86 | 3 | MM15908 | |
| Pathway | REACTOME_AZATHIOPRINE_ADME | 5.77e-04 | 27 | 86 | 3 | MM15693 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | SETX MAP7D3 MAP4 POLDIP3 CHAF1A YY1 CIC PCF11 RIF1 SLF2 UBTF ARID2 MDC1 KMT2A AATF KIF18B STAG2 RSBN1L EPB41 | 8.84e-10 | 954 | 121 | 19 | 36373674 |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | SETX SETD1B POLDIP3 ITSN1 LRSAM1 TTC4 PIAS2 CIC SYNJ1 SLF2 ARID2 RAB11FIP5 DIAPH3 SIPA1L2 CFAP44 | 2.30e-09 | 588 | 121 | 15 | 38580884 |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | ANK2 MAP7D3 MAP4 POLDIP3 TNRC6B OCRL CIC RIF1 SYNJ1 UBTF ARID2 KMT2A PRR14L NOPCHAP1 SIPA1L2 RSBN1L EPB41 | 2.75e-08 | 934 | 121 | 17 | 33916271 |
| Pubmed | ISLR2 CHAF1A AOX1 TNRC6B REV3L ZZEF1 YY1 INO80D SCAF1 ZFHX4 ARID2 RAB11FIP5 KIF18B SIPA1L2 RSBN1L WWC1 LRRC41 SPATC1L | 6.43e-08 | 1116 | 121 | 18 | 31753913 | |
| Pubmed | DMXL2 ANK2 SYNM ITSN1 LRSAM1 PARVB VPS26A DZIP1 RILPL1 FTCD REV3L PIAS2 SMYD2 SYNJ1 ZNF532 SLF2 ANKRD36 RSBN1L SPATC1L | 1.03e-07 | 1285 | 121 | 19 | 35914814 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | SETX MAP7D3 POLDIP3 FA2H CHAF1A YY1 INO80D CIC SCAF1 RIF1 PRDM11 SLF2 UBTF NFIX MDC1 KMT2A AATF KIF18B STAG2 | 1.15e-07 | 1294 | 121 | 19 | 30804502 |
| Pubmed | 1.64e-07 | 4 | 121 | 3 | 1526290 | ||
| Pubmed | 1.64e-07 | 4 | 121 | 3 | 16786188 | ||
| Pubmed | 1.64e-07 | 4 | 121 | 3 | 6330685 | ||
| Pubmed | 1.64e-07 | 4 | 121 | 3 | 12557262 | ||
| Pubmed | 1.64e-07 | 4 | 121 | 3 | 1728405 | ||
| Pubmed | Glutathione S-transferase A1 (GSTA1) release, an early indicator of acute hepatic injury in mice. | 1.64e-07 | 4 | 121 | 3 | 24964013 | |
| Pubmed | 1.64e-07 | 4 | 121 | 3 | 2049074 | ||
| Pubmed | Glutathione S-transferase A1 - a sensitive marker of alcoholic injury on primary hepatocytes. | 1.64e-07 | 4 | 121 | 3 | 27198676 | |
| Pubmed | 1.64e-07 | 4 | 121 | 3 | 19029078 | ||
| Pubmed | Mouse glutathione S-transferase Ya subunit: gene structure and sequence. | 1.64e-07 | 4 | 121 | 3 | 3652905 | |
| Pubmed | 1.64e-07 | 4 | 121 | 3 | 9606968 | ||
| Pubmed | 5'-flanking sequence of mouse glutathione S-transferase Ya gene. | 1.64e-07 | 4 | 121 | 3 | 2893339 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | SETX CHAF1A PIAS2 YY1 CIC RIF1 UBTF ARID2 MDC1 KMT2A KIF18B STAG2 LRRC41 | 2.20e-07 | 608 | 121 | 13 | 36089195 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | SETX MAP7D3 MAP4 DOCK11 RALGAPB DZIP1 CIC SYNJ1 SLF2 RAB11FIP5 KMT2A SIPA1L2 CSPP1 PCDH7 EPB41 | 3.37e-07 | 861 | 121 | 15 | 36931259 |
| Pubmed | 4.09e-07 | 5 | 121 | 3 | 12020353 | ||
| Pubmed | 4.09e-07 | 5 | 121 | 3 | 9268051 | ||
| Pubmed | Tissue-specific induction of murine glutathione transferase mRNAs by butylated hydroxyanisole. | 4.09e-07 | 5 | 121 | 3 | 3417659 | |
| Pubmed | Expression pattern of GSTP1 and GSTA1 in the pathogenesis of asthma. | 4.09e-07 | 5 | 121 | 3 | 23647087 | |
| Pubmed | 4.09e-07 | 5 | 121 | 3 | 11851347 | ||
| Pubmed | 4.09e-07 | 5 | 121 | 3 | 16243960 | ||
| Pubmed | SOX5 POLDIP3 TNRC6B ZHX2 PIAS2 YY1 INO80D CIC PCF11 FHAD1 RIF1 ZFHX4 UBTF NFIX ARID2 MDC1 KMT2A VGLL4 PCDH7 | 5.22e-07 | 1429 | 121 | 19 | 35140242 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | MAP4 CHAF1A ITSN1 RALGAPB YY1 CIC PCF11 SCAF1 RIF1 RPAP1 MDC1 KMT2A PCDH7 STAG2 | 5.48e-07 | 774 | 121 | 14 | 15302935 |
| Pubmed | Zonal expression and activity of glutathione S-transferase enzymes in the mouse olfactory mucosa. | 8.15e-07 | 6 | 121 | 3 | 14672804 | |
| Pubmed | DMXL2 ANK2 SYNM ITSN1 SUN1 RALGAPB DZIP1 PCF11 RPAP1 UBTF PRKAR1B RAB11FIP5 TOMM34 DIAPH3 SIPA1L2 CSPP1 PCDH7 EIF2AK3 LRRC41 | 9.46e-07 | 1487 | 121 | 19 | 33957083 | |
| Pubmed | SETX MAP4 CHAF1A RALGAPB TNRC6B GPRC5C ZHX2 INO80D CIC PCF11 SCAF1 RIF1 ARID2 MDC1 KMT2A AATF STAG2 RSBN1L EPB41 | 1.04e-06 | 1497 | 121 | 19 | 31527615 | |
| Pubmed | 1.42e-06 | 7 | 121 | 3 | 10668202 | ||
| Pubmed | 1.42e-06 | 7 | 121 | 3 | 1427837 | ||
| Pubmed | 1.42e-06 | 7 | 121 | 3 | 7894162 | ||
| Pubmed | 1.42e-06 | 7 | 121 | 3 | 8584275 | ||
| Pubmed | 1.43e-06 | 100 | 121 | 6 | 10048485 | ||
| Pubmed | PIK3AP1 POLDIP3 CHAF1A ITSN1 SUN1 TNRC6B GPRC5C TTC4 YY1 MDC1 TOMM34 PRR14L RSBN1L | 1.77e-06 | 733 | 121 | 13 | 34672954 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | SETX MAP7D3 CHAF1A REV3L CBFA2T3 YY1 CIC SMYD2 RIF1 ZFHX4 NFIX EIF2AK3 STAG2 LRRC41 | 1.81e-06 | 857 | 121 | 14 | 25609649 |
| Pubmed | 2.27e-06 | 8 | 121 | 3 | 7774561 | ||
| Pubmed | 2.27e-06 | 8 | 121 | 3 | 14675547 | ||
| Pubmed | 2.27e-06 | 8 | 121 | 3 | 16284450 | ||
| Pubmed | MAP7D3 REV3L NEB PIAS2 CIC PTPRN2 ARID2 RAB11FIP5 AATF CSPP1 STAG2 LRRC41 | 2.49e-06 | 638 | 121 | 12 | 31182584 | |
| Pubmed | Mapping genes encoding drug-metabolizing enzymes in recombinant inbred mice. | 3.40e-06 | 9 | 121 | 3 | 1685137 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | ZNF704 MAP4 RALGAPB TNRC6B PARVB RILPL1 ZHX2 PTPRG ZNF532 PTPRN2 NFIX TBCK PRKAR1B VGLL4 ZRANB1 STAG2 EPB41 LRRC41 | 4.09e-06 | 1489 | 121 | 18 | 28611215 |
| Pubmed | 4.84e-06 | 10 | 121 | 3 | 15870285 | ||
| Pubmed | 4.84e-06 | 10 | 121 | 3 | 1981995 | ||
| Pubmed | 6.64e-06 | 11 | 121 | 3 | 15100242 | ||
| Pubmed | Nox4 regulates Nrf2 and glutathione redox in cardiomyocytes in vivo. | 6.64e-06 | 11 | 121 | 3 | 21554947 | |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 7.08e-06 | 283 | 121 | 8 | 30585729 | |
| Pubmed | 8.21e-06 | 486 | 121 | 10 | 20936779 | ||
| Pubmed | MEK2 is a kinase related to MEK1 and is differentially expressed in murine tissues. | 8.83e-06 | 12 | 121 | 3 | 8297798 | |
| Pubmed | 1.15e-05 | 13 | 121 | 3 | 9441664 | ||
| Pubmed | 1.15e-05 | 13 | 121 | 3 | 36421460 | ||
| Pubmed | 1.15e-05 | 13 | 121 | 3 | 2572508 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 3031680 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 11668220 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 33674626 | ||
| Pubmed | Human liver glutathione S-transferases: complete primary sequence of an Ha subunit cDNA. | 1.20e-05 | 2 | 121 | 2 | 3800996 | |
| Pubmed | Nucleotide sequence of the human liver glutathione S-transferase subunit 1 cDNA. | 1.20e-05 | 2 | 121 | 2 | 3678589 | |
| Pubmed | The basic glutathione S-transferases from human livers are products of separate genes. | 1.20e-05 | 2 | 121 | 2 | 3036131 | |
| Pubmed | Rationale for targeting BCL6 in MLL-rearranged acute lymphoblastic leukemia. | 1.20e-05 | 2 | 121 | 2 | 31395741 | |
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 21163259 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 15128049 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 21844655 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 11692074 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 30511336 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 3138230 | ||
| Pubmed | Heterologous expression of recombinant human glutathione transferase A1-1 from a hepatoma cell line. | 1.20e-05 | 2 | 121 | 2 | 1330133 | |
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 19639209 | ||
| Pubmed | Characterization of two novel subunits of the alpha-class glutathione S-transferases of human liver. | 1.20e-05 | 2 | 121 | 2 | 8431482 | |
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 2604726 | ||
| Pubmed | TPP2 SUN1 RALGAPB CIC PCF11 RIF1 PTPRG PTPRN2 UBTF RAB11FIP5 AATF CSPP1 TNS1 PCDH7 | 1.79e-05 | 1049 | 121 | 14 | 27880917 | |
| Pubmed | SETX MAP7D3 SYNM TNRC6B GPRC5C OCRL PCF11 RIF1 RAB11FIP5 TOMM34 PCDH7 EPB41 | 1.80e-05 | 777 | 121 | 12 | 35844135 | |
| Pubmed | 2.23e-05 | 16 | 121 | 3 | 8649810 | ||
| Pubmed | MAP7D3 MAP4 TNRC6B SYNJ1 ARID2 MDC1 KMT2A DIAPH3 RSBN1L EPB41 | 2.34e-05 | 549 | 121 | 10 | 38280479 | |
| Pubmed | 3.06e-05 | 347 | 121 | 8 | 17114649 | ||
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 10676639 | ||
| Pubmed | The SUMO Conjugation Complex Self-Assembles into Nuclear Bodies Independent of SIZ1 and COP1. | 3.59e-05 | 3 | 121 | 2 | 30389781 | |
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 19710696 | ||
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 12093480 | ||
| Pubmed | Coeliac disease-associated risk variants in TNFAIP3 and REL implicate altered NF-kappaB signalling. | 4.15e-05 | 265 | 121 | 7 | 19240061 | |
| Pubmed | CACNA1E MYLK ANK2 MYH7B CHAF1A ITSN1 NEB JSRP1 YY1 PCF11 LMOD3 KMT2A AATF DIAPH3 SIPA1L2 STAG2 | 4.16e-05 | 1442 | 121 | 16 | 35575683 | |
| Pubmed | 4.27e-05 | 472 | 121 | 9 | 38943005 | ||
| Pubmed | Immunohistochemical localization of glutathione S-transferases in human lung. | 7.17e-05 | 4 | 121 | 2 | 8242618 | |
| Pubmed | 7.17e-05 | 4 | 121 | 2 | 8307579 | ||
| Pubmed | 7.17e-05 | 4 | 121 | 2 | 20431063 | ||
| Pubmed | 7.17e-05 | 4 | 121 | 2 | 12139976 | ||
| Pubmed | Genome-wide survey and developmental expression mapping of zebrafish SET domain-containing genes. | 7.17e-05 | 4 | 121 | 2 | 18231586 | |
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | 7.47e-05 | 394 | 121 | 8 | 27248496 | |
| Pubmed | Resveratrol improves health and survival of mice on a high-calorie diet. | 1.01e-04 | 26 | 121 | 3 | 17086191 | |
| Pubmed | 1.19e-04 | 5 | 121 | 2 | 25561738 | ||
| Pubmed | Tal, a Tsg101-specific E3 ubiquitin ligase, regulates receptor endocytosis and retrovirus budding. | 1.19e-04 | 5 | 121 | 2 | 15256501 | |
| Pubmed | 1.19e-04 | 5 | 121 | 2 | 9383296 | ||
| Pubmed | 1.19e-04 | 5 | 121 | 2 | 23650189 | ||
| Pubmed | 1.19e-04 | 5 | 121 | 2 | 37074193 | ||
| Pubmed | 1.26e-04 | 28 | 121 | 3 | 29365100 | ||
| Pubmed | TPP2 SETX MAP4 POLDIP3 YY1 INO80D CIC PCF11 UBTF ARID2 KMT2A TOMM34 STAG2 | 1.27e-04 | 1103 | 121 | 13 | 34189442 | |
| Pubmed | TPP2 CACNA1E DMXL2 ANK2 DOCK11 ITSN1 TNRC6B SHANK3 SYNJ1 PTPRN2 PRKAR1B TNS1 | 1.40e-04 | 963 | 121 | 12 | 28671696 | |
| Pubmed | 1.45e-04 | 226 | 121 | 6 | 31452512 | ||
| Pubmed | 1.56e-04 | 30 | 121 | 3 | 20200426 | ||
| Interaction | GSTA2 interactions | 2.21e-07 | 10 | 117 | 4 | int:GSTA2 | |
| Interaction | SMC5 interactions | SETX MAP7D3 MAP4 POLDIP3 CHAF1A REV3L YY1 CIC PCF11 RIF1 SLF2 UBTF ARID2 MDC1 KMT2A AATF KIF18B ZRANB1 STAG2 RSBN1L EPB41 | 2.76e-07 | 1000 | 117 | 21 | int:SMC5 |
| Interaction | NUP43 interactions | SETX SETD1B MAP4 TNRC6B RILPL1 ZHX2 SCAF1 RIF1 ZNF532 SLF2 UBTF ARID2 MDC1 KMT2A AATF ZRANB1 | 6.68e-07 | 625 | 117 | 16 | int:NUP43 |
| Interaction | NAA40 interactions | TPP2 ANK2 MAP7D3 MAP4 POLDIP3 TNRC6B OCRL CIC RIF1 SYNJ1 UBTF ARID2 KMT2A PRR14L NOPCHAP1 SIPA1L2 ZRANB1 RSBN1L EPB41 | 3.46e-06 | 978 | 117 | 19 | int:NAA40 |
| Interaction | H3C3 interactions | SETX CHAF1A PIAS2 YY1 CIC RIF1 UBTF ARID2 MDC1 KMT2A KIF18B STAG2 LRRC41 | 6.13e-06 | 495 | 117 | 13 | int:H3C3 |
| Interaction | TEAD1 interactions | 8.76e-06 | 176 | 117 | 8 | int:TEAD1 | |
| Interaction | ZNF330 interactions | POLDIP3 CHAF1A PIAS2 YY1 UBTF ARID2 KMT2A AATF KIF18B STAG2 RSBN1L LRRC41 | 1.12e-05 | 446 | 117 | 12 | int:ZNF330 |
| Interaction | CENPA interactions | CHAF1A PIAS2 YY1 SLF2 UBTF KMT2A AATF DIAPH3 KIF18B STAG2 LRRC41 | 1.25e-05 | 377 | 117 | 11 | int:CENPA |
| Interaction | GSTA5 interactions | 1.56e-05 | 9 | 117 | 3 | int:GSTA5 | |
| Interaction | H3C1 interactions | SETD1B ANK2 CHAF1A NEB ZZEF1 YY1 RIF1 UBTF ARID2 MDC1 KMT2A PRR14L KIF18B ZRANB1 STAG2 RSBN1L WWC1 | 1.75e-05 | 901 | 117 | 17 | int:H3C1 |
| Interaction | SNRNP40 interactions | SETX POLDIP3 ZHX2 YY1 SCAF1 ZNF532 UBTF ARID2 MDC1 KMT2A AATF ZRANB1 ADAT1 RSBN1L | 1.98e-05 | 637 | 117 | 14 | int:SNRNP40 |
| Interaction | FEV interactions | 2.46e-05 | 203 | 117 | 8 | int:FEV | |
| Interaction | BRD3 interactions | ISLR2 CHAF1A BCL6 INO80D SCAF1 RIF1 UBTF MDC1 RAB11FIP5 KMT2A ZRANB1 RSBN1L | 3.07e-05 | 494 | 117 | 12 | int:BRD3 |
| Interaction | GSTA4 interactions | 4.04e-05 | 12 | 117 | 3 | int:GSTA4 | |
| Interaction | SOX5 interactions | 4.50e-05 | 162 | 117 | 7 | int:SOX5 | |
| Interaction | RIF1 interactions | 5.12e-05 | 225 | 117 | 8 | int:RIF1 | |
| Interaction | KANSL2 interactions | 5.42e-05 | 70 | 117 | 5 | int:KANSL2 | |
| Interaction | NFIX interactions | 5.45e-05 | 227 | 117 | 8 | int:NFIX | |
| Interaction | PPIA interactions | POLDIP3 ITSN1 TNRC6B TTC4 PIAS2 YY1 SHANK3 CIC RIF1 PTPRG ARID2 RAB11FIP5 ANKRD36 VGLL4 ZRANB1 EPB41 | 5.48e-05 | 888 | 117 | 16 | int:PPIA |
| Interaction | PAX6 interactions | 5.50e-05 | 366 | 117 | 10 | int:PAX6 | |
| Interaction | H2BC9 interactions | POLDIP3 OCRL NEB JSRP1 YY1 SCAF1 FHAD1 ZFHX4 MDC1 ANKRD36 CFAP44 | 5.83e-05 | 446 | 117 | 11 | int:H2BC9 |
| Interaction | YY1 interactions | 6.83e-05 | 454 | 117 | 11 | int:YY1 | |
| Interaction | MCRS1 interactions | 6.94e-05 | 235 | 117 | 8 | int:MCRS1 | |
| Interaction | ELK3 interactions | 7.18e-05 | 120 | 117 | 6 | int:ELK3 | |
| Interaction | FOXN1 interactions | 8.39e-05 | 40 | 117 | 4 | int:FOXN1 | |
| Interaction | BRMS1L interactions | 9.00e-05 | 125 | 117 | 6 | int:BRMS1L | |
| Interaction | RAB11A interactions | DMXL2 POLDIP3 ITSN1 SUN1 RALGAPB GPRC5C OCRL RILPL1 RAB11FIP5 AATF AKAP10 DIAPH3 PCDH7 ZRANB1 EPB41 | 9.24e-05 | 830 | 117 | 15 | int:RAB11A |
| Interaction | NRCAM interactions | 9.26e-05 | 41 | 117 | 4 | int:NRCAM | |
| Interaction | ELF1 interactions | 9.41e-05 | 126 | 117 | 6 | int:ELF1 | |
| Interaction | NSMCE1 interactions | 1.02e-04 | 42 | 117 | 4 | int:NSMCE1 | |
| Interaction | LHX3 interactions | 1.04e-04 | 185 | 117 | 7 | int:LHX3 | |
| Interaction | KMT2B interactions | 1.12e-04 | 130 | 117 | 6 | int:KMT2B | |
| Interaction | H3-3A interactions | SETD1B CHAF1A VPS26A PIAS2 YY1 CIC RIF1 UBTF ARID2 MDC1 KMT2A KIF18B STAG2 LRRC41 | 1.13e-04 | 749 | 117 | 14 | int:H3-3A |
| Interaction | CXXC1 interactions | 1.22e-04 | 132 | 117 | 6 | int:CXXC1 | |
| Interaction | ZZZ3 interactions | 1.61e-04 | 139 | 117 | 6 | int:ZZZ3 | |
| Interaction | C5orf24 interactions | 1.72e-04 | 48 | 117 | 4 | int:C5orf24 | |
| Interaction | BRD2 interactions | 2.02e-04 | 429 | 117 | 10 | int:BRD2 | |
| Interaction | YWHAZ interactions | DMXL2 MAP7D3 DOCK11 CHAF1A RALGAPB DZIP1 NEB ZHX2 SHANK3 CIC MDC1 RAB11FIP5 KMT2A PRR14L SIPA1L2 TNS1 PCDH7 ZRANB1 EPB41 | 2.07e-04 | 1319 | 117 | 19 | int:YWHAZ |
| Interaction | YWHAH interactions | SETX MAP7D3 DOCK11 RALGAPB DZIP1 PIAS2 CIC SYNJ1 SLF2 RAB11FIP5 KMT2A SIPA1L2 CSPP1 ZRANB1 EPB41 FRMD5 WWC1 | 2.09e-04 | 1102 | 117 | 17 | int:YWHAH |
| Interaction | HDAC1 interactions | BHLHE41 CHAF1A TNRC6B BCL6 CBFA2T3 ZHX2 TTC4 YY1 CIC ZFHX4 SYNJ1 UBTF NFIX KMT2A DIAPH3 ZRANB1 STAG2 | 2.22e-04 | 1108 | 117 | 17 | int:HDAC1 |
| Interaction | MSANTD2 interactions | 2.35e-04 | 21 | 117 | 3 | int:MSANTD2 | |
| Interaction | WDR82 interactions | 2.48e-04 | 213 | 117 | 7 | int:WDR82 | |
| Interaction | GSTA1 interactions | 2.71e-04 | 22 | 117 | 3 | int:GSTA1 | |
| Interaction | SP1 interactions | 2.82e-04 | 365 | 117 | 9 | int:SP1 | |
| Interaction | POLR2A interactions | SETX SETD1B MAP4 CIC SMYD2 PCF11 SCAF1 RPAP1 MDC1 KMT2A ZRANB1 | 2.91e-04 | 536 | 117 | 11 | int:POLR2A |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 1.15e-05 | 34 | 75 | 4 | 487 | |
| GeneFamily | Zinc fingers C2H2-type|PR/SET domain family | 4.47e-05 | 17 | 75 | 3 | 1197 | |
| GeneFamily | Glutathione S-transferases | 1.48e-04 | 25 | 75 | 3 | 567 | |
| GeneFamily | Zinc fingers MYND-type|A-kinase anchoring proteins | 2.32e-04 | 29 | 75 | 3 | 396 | |
| GeneFamily | INO80 complex |SRCAP complex | 1.72e-03 | 15 | 75 | 2 | 595 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 1.72e-03 | 15 | 75 | 2 | 529 | |
| GeneFamily | Protein tyrosine phosphatases, receptor type | 3.39e-03 | 21 | 75 | 2 | 813 | |
| GeneFamily | Zinc fingers MYND-type | 3.39e-03 | 21 | 75 | 2 | 87 | |
| GeneFamily | Fibrinogen C domain containing | 4.79e-03 | 25 | 75 | 2 | 554 | |
| GeneFamily | Sterile alpha motif domain containing | 5.84e-03 | 88 | 75 | 3 | 760 | |
| Coexpression | GSE29949_MICROGLIA_VS_DC_BRAIN_UP | 3.54e-07 | 199 | 120 | 9 | M8399 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | CACNA1E SYCP2L ANK2 OCRL REV3L NEB PIAS2 SHANK3 CCDC112 LMOD3 ZFHX4 SYNJ1 NFIX DCLK3 PRKAR1B ANKRD36 PCDH7 EPB41 FRMD5 | 6.67e-07 | 1106 | 120 | 19 | M39071 |
| Coexpression | GSE6259_33D1_POS_VS_DEC205_POS_SPLENIC_DC_UP | 3.11e-06 | 193 | 120 | 8 | M6730 | |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN | BHLHE41 KLHL24 MYLK TNRC6B RILPL1 INO80D PTPRG UBTF ARID2 AKAP10 VGLL4 NOPCHAP1 TNS1 EPB41 WWC1 | 4.37e-06 | 807 | 120 | 15 | M16651 |
| Coexpression | GSE19888_CTRL_VS_A3R_ACTIVATION_MAST_CELL_UP | 3.77e-05 | 199 | 120 | 7 | M7325 | |
| CoexpressionAtlas | Stem Cells, SC.LTSL.BM, CD117+ IL7R- CD150+ CD48- AA4.1+ CD43+, Bone marrow, avg-1 | ZNF704 DMXL2 ITSN1 OCRL CBFA2T3 SHANK3 SMYD2 CCDC112 ZNF532 NFIX DIAPH3 TNS1 PCDH7 | 5.12e-07 | 409 | 119 | 13 | GSM476663_500 |
| CoexpressionAtlas | Stem Cells, SC.LTSL.BM, IgM- CD24- CD117+ IL7R- CD150+ CD48- AA4.1+ CD43+, Bone marrow, avg-2 | DMXL2 ITSN1 OCRL CBFA2T3 SHANK3 SMYD2 ZNF532 NFIX DIAPH3 KIF18B TNS1 PCDH7 | 4.53e-06 | 422 | 119 | 12 | GSM399442_500 |
| CoexpressionAtlas | Stem Cells, SC.STSL.BM, CD117+ IL7R- CD150- CD48- AA4.1+ CD43+, Bone marrow, avg-3 | ZNF704 DMXL2 ITSN1 OCRL CBFA2T3 SHANK3 SMYD2 ZNF532 NFIX DIAPH3 TNS1 | 2.64e-05 | 423 | 119 | 11 | GSM399454_500 |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.31e-09 | 187 | 121 | 9 | c41a2c81dd2ceef303f39f699032aa7d6ea67cf0 | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 3.98e-09 | 199 | 121 | 9 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.02e-07 | 190 | 121 | 7 | 1cf023e3c6924d6a06f353d4b62444b6f2fee8a7 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell-Ascending_Thin_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.02e-07 | 190 | 121 | 7 | 59bbbd2c8d4b7ce46c54ca8022b1557e7e5eee2a | |
| ToppCell | ILEUM-inflamed-(7)_Endothelial_cell-(7)_Lymphatics|(7)_Endothelial_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 9.67e-07 | 192 | 121 | 7 | d43caf42ec744e895137f31ef65a990e250669d2 | |
| ToppCell | (10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition | 1.23e-06 | 199 | 121 | 7 | 61b1ed2db71b96157b92b7535d1955a4033098da | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.23e-06 | 199 | 121 | 7 | 5d2e85e40b6b52b1809e680b952913d77215b3d0 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Glial-Neuronal-Oligodendrocyte|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.23e-06 | 199 | 121 | 7 | 9dd4b17fb8c70ab9e126b23b72600463f3db832d | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.23e-06 | 199 | 121 | 7 | 6fb5f931e6217142de38c1fffc011e63bda4772b | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Glial-Neuronal|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.23e-06 | 199 | 121 | 7 | 1bb5797e8e0552bf9b44bf4c958d1aa6dbe6c756 | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Macrophage_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.27e-06 | 200 | 121 | 7 | a443e475e7a10c26a6173d1af961de6219e0e567 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-myofibroblast_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.24e-06 | 166 | 121 | 6 | 94636dbc039f794c735960c3425e00bdd5523602 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell-Degenerative_Ascending_Thin_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.16e-06 | 174 | 121 | 6 | 46bd0ef7d0541386de7a901d85d53d0176dc92bf | |
| ToppCell | droplet-Liver-LIVER_HEP-30m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.90e-06 | 180 | 121 | 6 | dd1b10c7f5a0fbc63163844ca1882884a24a84d3 | |
| ToppCell | droplet-Liver-LIVER_HEP|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.90e-06 | 180 | 121 | 6 | 423454e3390080ae03bb3cbb267255ebfe4df080 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.02e-05 | 181 | 121 | 6 | 9d782ba5cf5a172cb4f447763fc50e5b13ef7dd9 | |
| ToppCell | RV|World / Chamber and Cluster_Paper | 1.02e-05 | 181 | 121 | 6 | bbe1e6e59d8889bd37d6e8303116cbdcafca7236 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.05e-05 | 182 | 121 | 6 | eb138aa1dca9373f1586600f258df06dcf56d81f | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.19e-05 | 186 | 121 | 6 | f0c8de4f6ae9047b9108a47a2af8c5f42bc103b0 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.23e-05 | 187 | 121 | 6 | c31130fc2f9f882944b2ba366a034a03f051c4b9 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 1.27e-05 | 188 | 121 | 6 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 1.31e-05 | 189 | 121 | 6 | 5e80c47f63980904c4c1ff02c201b67b456a0974 | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 1.35e-05 | 190 | 121 | 6 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-05 | 191 | 121 | 6 | 7d1595e616f6f111fc2f5bc1b179c5d67d624cc9 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.39e-05 | 191 | 121 | 6 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.43e-05 | 192 | 121 | 6 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.47e-05 | 193 | 121 | 6 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | Bronchial-NucSeq-Stromal-Schwann|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.61e-05 | 196 | 121 | 6 | a90c76d9c57a4491b94a321ba541b792ec5d8e83 | |
| ToppCell | Children_(3_yrs)-Mesenchymal|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.61e-05 | 196 | 121 | 6 | bc94909f9b2dc08a59eef1914148b69720569c8f | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.61e-05 | 196 | 121 | 6 | 7d8505dac15fa59935ccf592afc54b04c4c6554f | |
| ToppCell | Epithelial_cells-Epithelial_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 1.70e-05 | 198 | 121 | 6 | 52e9d41a1726bc1140df6baec9f17a534448ac8b | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Macrophage_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.70e-05 | 198 | 121 | 6 | e125eb8aa57c172e5518874da1bd25998292f5e2 | |
| ToppCell | nucseq-Mesenchymal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.70e-05 | 198 | 121 | 6 | 8f52243ca8b9ba68a75ae411506a3a6de258eb97 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Newborn-35|World / Primary Cells by Cluster | 1.70e-05 | 198 | 121 | 6 | de5214a85fe017eb23d4aa8af624464f062ec57e | |
| ToppCell | Epithelial_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 1.70e-05 | 198 | 121 | 6 | eeec789d226171f30799577cc37c07bdced2e3cb | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 1.75e-05 | 199 | 121 | 6 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.75e-05 | 199 | 121 | 6 | e1849505b92820a219c5a2c35492bdd55579fb48 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.75e-05 | 199 | 121 | 6 | 6b3a0e5d52a30d0eed30e6a670f5b53bc233f70c | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.75e-05 | 199 | 121 | 6 | 8b86c69aaf60feff53aa782559cfece7342a23de | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.80e-05 | 200 | 121 | 6 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | Bronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.80e-05 | 200 | 121 | 6 | 389cc775c8419d90fb77cd794376d2160a7bf44e | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Pericyte-Pericyte_2|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.80e-05 | 200 | 121 | 6 | d2fcd3bd7c3223875f027eeb48ff621192a5f242 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.80e-05 | 200 | 121 | 6 | 87827041663013f5e7273168dc8709d69840e7ce | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Pericyte-Pericyte_2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.80e-05 | 200 | 121 | 6 | 786f1ae53e60b5ffbf4bfd393d10b802478148b3 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 1.80e-05 | 200 | 121 | 6 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Macrophage_alveolar-Macro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.80e-05 | 200 | 121 | 6 | ed785a6d08ca2b350dc3307b587eadfb2886d1f9 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L2/3_IT-L2/3_IT_VISp_Agmat|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 6.76e-05 | 156 | 121 | 5 | 09e0702400570089d9012dcf94dfb4827c97e49d | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma-3|TCGA-Skin / Sample_Type by Project: Shred V9 | 7.39e-05 | 159 | 121 | 5 | fb222c42f66901852b01cec073ec0732245ee973 | |
| ToppCell | Adult-Mesenchymal-chondrocyte|Adult / Lineage, Cell type, age group and donor | 7.39e-05 | 159 | 121 | 5 | 3f7305ee76447064b5c846c4f576360a2f7e0b7c | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L2/3_IT|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 7.84e-05 | 161 | 121 | 5 | e3327c296d48e821004e61a573abb75624a6f040 | |
| ToppCell | Endothelial-B-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 9.06e-05 | 166 | 121 | 5 | c286987ea4e511195607c87ec4529c2c2ed2122e | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Stem_cells-neuroepithelial-like_cells|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 9.32e-05 | 167 | 121 | 5 | e488d9c7cf4355959e3833de3bd496c13fc11b1b | |
| ToppCell | TCGA-Endometrium-Solid_Tissue_Normal-Endometrium_normal_tissue-Endometrium-7|TCGA-Endometrium / Sample_Type by Project: Shred V9 | 9.59e-05 | 168 | 121 | 5 | a97e8e07ba949b30805aeed5f60fa5e092b9d3d4 | |
| ToppCell | E17.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.01e-04 | 170 | 121 | 5 | 7fa022471e14ac8a3bc147c793368a4d56a8e591 | |
| ToppCell | TCGA-Endometrium-Solid_Tissue_Normal-Endometrium_normal_tissue-Endometrium|TCGA-Endometrium / Sample_Type by Project: Shred V9 | 1.01e-04 | 170 | 121 | 5 | cdc19013da7c41d1ed8400a6a643e4c684ff9912 | |
| ToppCell | TCGA-Endometrium-Solid_Tissue_Normal|TCGA-Endometrium / Sample_Type by Project: Shred V9 | 1.01e-04 | 170 | 121 | 5 | 0bde0a40440c7fdf7ba89cac8831d4014e7a4807 | |
| ToppCell | TCGA-Endometrium-Solid_Tissue_Normal-Endometrium_normal_tissue|TCGA-Endometrium / Sample_Type by Project: Shred V9 | 1.01e-04 | 170 | 121 | 5 | 516b38c4ecf6b0b04c5d4f80c510dcc00b328c6f | |
| ToppCell | facs-Lung-24m-Epithelial-airway_epithelial-club_cell-club_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.04e-04 | 171 | 121 | 5 | 8ed98f223143bd81d9819e9a420eb9cc81ee6c53 | |
| ToppCell | facs-Lung-24m-Epithelial-airway_epithelial-club_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.04e-04 | 171 | 121 | 5 | bd339e482f09a3fa04b086029b94f45205b8a6c5 | |
| ToppCell | COVID-19-kidney-PEC|kidney / Disease (COVID-19 only), tissue and cell type | 1.07e-04 | 172 | 121 | 5 | 36a96714a0eb6ac438648135336c9791881ddadb | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_PRSS12|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.22e-04 | 177 | 121 | 5 | f902600c639087664316b3cf30cab243bc3d1c5c | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage_3|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.22e-04 | 177 | 121 | 5 | 3d955ea938a1d2fb1b6d68d4997fd454bd632dfc | |
| ToppCell | droplet-Limb_Muscle-nan-24m-Endothelial-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.26e-04 | 178 | 121 | 5 | f2002a5c4758d0af6c1880ca12f0af0d5e8888e4 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell-Ascending_Thin_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.29e-04 | 179 | 121 | 5 | 55bc69f107fc710db7617c428575792adfdbbcc1 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.36e-04 | 181 | 121 | 5 | 451b87ac95154bb80018b8dd245b4a6389d81411 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.43e-04 | 183 | 121 | 5 | 83592c332b1e82673f993d37c7f480befdc3dcda | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.43e-04 | 183 | 121 | 5 | 12daaea821e49bc94a01e2496331e92a80d27339 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.47e-04 | 184 | 121 | 5 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | droplet-Lung-nan-3m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.51e-04 | 185 | 121 | 5 | 6a85399cfdb9b89683c874e7f046957f9a601dc2 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.51e-04 | 185 | 121 | 5 | 6712512100ccef456d2e2bd201d0987986c92ac9 | |
| ToppCell | COVID-19-Fibroblasts-Adventitial_FB|COVID-19 / group, cell type (main and fine annotations) | 1.51e-04 | 185 | 121 | 5 | a5aebf2b9b05b550d021272731d68af9a6b1229d | |
| ToppCell | COVID-19-kidney-FLT1+PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.51e-04 | 185 | 121 | 5 | 673308ca0514a4d3629d61fe91e9d8fb31b72166 | |
| ToppCell | COPD-Lymphoid-B|COPD / Disease state, Lineage and Cell class | 1.51e-04 | 185 | 121 | 5 | 925e79c35c381dd44ec5fb921dca09ce43140135 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.51e-04 | 185 | 121 | 5 | e64e8c98dd88d91f6501d3fb10b60fd2f3c90af3 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.51e-04 | 185 | 121 | 5 | eb7d3c1363d5fedc611f9c1a91ea823de251355e | |
| ToppCell | droplet-Lung-nan-3m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.51e-04 | 185 | 121 | 5 | 64791056cdbb739136dbef08f4b16e2b5427faad | |
| ToppCell | pdx|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.54e-04 | 186 | 121 | 5 | de8e538c8767d41b8a52f5e58ba1affd4e7244c4 | |
| ToppCell | pdx-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.54e-04 | 186 | 121 | 5 | 0b88a87158a9ca8de3bf40a4ff1687150707a5f0 | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-mLN_Stroma_(FMO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.54e-04 | 186 | 121 | 5 | 7582b5154d8e5a4434817b5ab77a10b789ea2288 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_B-B_plasma|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.58e-04 | 187 | 121 | 5 | 88d20f150df61ef0e3ee0c3e9895b094920c4b09 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.58e-04 | 187 | 121 | 5 | 86250acf088ec0c4800a0dfa031b0d4f7e52c342 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_B-B_plasma-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.58e-04 | 187 | 121 | 5 | 158c2c003fd225ba61793fb06eece232fb063d05 | |
| ToppCell | RV-04._Ventricular_Cardiomyocyte_I|World / Chamber and Cluster_Paper | 1.58e-04 | 187 | 121 | 5 | 78cdcf8bc141d3b155c3c8af908431fc419c4d08 | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 1.62e-04 | 188 | 121 | 5 | 6d249fe92d51a19da19ec14bb2262d394255d577 | |
| ToppCell | remission-Platelet|World / disease stage, cell group and cell class | 1.62e-04 | 188 | 121 | 5 | fa69f20ef6b8ce620ba342f0984d40ddf259bc3f | |
| ToppCell | healthy_donor-Lymphocytic-Plasma_cell|healthy_donor / Disease condition, Lineage, Cell class and subclass | 1.62e-04 | 188 | 121 | 5 | bd53b0371154cff680226897b61c9809a239d1b6 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.62e-04 | 188 | 121 | 5 | af740fa78542438fdff627ea1f74f4eee43316be | |
| ToppCell | 15-Distal-RBC|Distal / Age, Tissue, Lineage and Cell class | 1.62e-04 | 188 | 121 | 5 | c68ccb1c5c21d13ddac09b16e7d466f0530bbda5 | |
| ToppCell | 15-Distal-RBC-RBC|Distal / Age, Tissue, Lineage and Cell class | 1.62e-04 | 188 | 121 | 5 | 2534684e4932c1255c24a26ca2277ac7af0a118b | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 1.66e-04 | 189 | 121 | 5 | 0a82931b5f6c0a6427ca3edd5e2235ac49099d40 | |
| ToppCell | COVID-19-Heart|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.70e-04 | 190 | 121 | 5 | 918ad5037881212008f9f69d5df5da91fd01422c | |
| ToppCell | pdx-Tumor_cells-T8|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.70e-04 | 190 | 121 | 5 | b05db0de9b6ae01dd30074453f7de44f7397631e | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.70e-04 | 190 | 121 | 5 | 45df8fee00f8949937863159d7aa042e72748d9b | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|LA / Chamber and Cluster_Paper | 1.75e-04 | 191 | 121 | 5 | 5d1b674eb7703830b7ce8bbeac3363cabd0e6ae9 | |
| ToppCell | wk_20-22-Endothelial-Lymph_endothelial|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.75e-04 | 191 | 121 | 5 | 631f95fd80dd3678b5b2ef201abf7fe646049af6 | |
| ToppCell | LV-04._Ventricular_Cardiomyocyte_I|LV / Chamber and Cluster_Paper | 1.79e-04 | 192 | 121 | 5 | ad19e2c1d36a0566c9b12ced10db78f4781c8ea6 | |
| ToppCell | LPS_only-Stromal_mesenchymal|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.79e-04 | 192 | 121 | 5 | 162d8b5858d150ecbbd1c9bf2b19c6c9cd50a158 | |
| ToppCell | Fibroblast-D_(Pericyte)|World / shred on cell class and cell subclass (v4) | 1.79e-04 | 192 | 121 | 5 | 8c13c351fcc3d88e8c2ffa017e71ff6272cc6fac | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)-hematologic-erythrocytic-erythrocyte|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.83e-04 | 193 | 121 | 5 | 305e15ee467826ee08b2617c69f250ad39c11b19 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.83e-04 | 193 | 121 | 5 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec | |
| Drug | Dubinidine [22964-77-8]; Down 200; 14.6uM; HL60; HT_HG-U133A | 9.51e-07 | 195 | 120 | 9 | 6131_DN | |
| Drug | quercetin 3-arabinopyranoside | 2.82e-06 | 6 | 120 | 3 | ctd:C428865 | |
| Drug | Medrysone [2668-66-8]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 8.95e-06 | 194 | 120 | 8 | 4727_DN | |
| Drug | Evoxine [522-11-2]; Down 200; 11.6uM; HL60; HT_HG-U133A | 9.64e-06 | 196 | 120 | 8 | 2186_DN | |
| Drug | Pindolol [13523-86-9]; Down 200; 16.2uM; HL60; HG-U133A | 1.00e-05 | 197 | 120 | 8 | 1392_DN | |
| Drug | aspirin, USP; Up 200; 100uM; MCF7; HT_HG-U133A_EA | 1.00e-05 | 197 | 120 | 8 | 1042_UP | |
| Drug | Chlorpheniramine maleate [113-92-8]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 1.04e-05 | 198 | 120 | 8 | 2217_DN | |
| Drug | Propranolol hydrochloride [318-98-9]; Up 200; 13.6uM; MCF7; HT_HG-U133A | 1.08e-05 | 199 | 120 | 8 | 5358_UP | |
| Drug | Chenodiol [474-25-9]; Down 200; 10.2uM; HL60; HT_HG-U133A | 1.08e-05 | 199 | 120 | 8 | 2402_DN | |
| Drug | haloperidol; Down 200; 10uM; MCF7; HT_HG-U133A | 1.08e-05 | 199 | 120 | 8 | 6923_DN | |
| Drug | Strophanthidin [66-28-4]; Down 200; 9.8uM; MCF7; HT_HG-U133A | 1.12e-05 | 200 | 120 | 8 | 7182_DN | |
| Drug | Dcvg | 2.07e-05 | 31 | 120 | 4 | CID006437359 | |
| Drug | dimethoxystrychnine | 3.39e-05 | 35 | 120 | 4 | CID000009649 | |
| Drug | Dixan | 3.39e-05 | 35 | 120 | 4 | CID000010404 | |
| Drug | 17-AAG; Down 200; 1uM; PC3; HT_HG-U133A | 6.56e-05 | 189 | 120 | 7 | 1206_DN | |
| Drug | Thiostrepton [1393-48-2]; Down 200; 2.4uM; MCF7; HT_HG-U133A | 6.78e-05 | 190 | 120 | 7 | 4385_DN | |
| Drug | Rescinnamin [24815-24-5]; Down 200; 6.4uM; MCF7; HT_HG-U133A | 7.24e-05 | 192 | 120 | 7 | 2785_DN | |
| Drug | geldanamycin; Down 200; 1uM; PC3; HT_HG-U133A | 7.48e-05 | 193 | 120 | 7 | 1228_DN | |
| Drug | Pronethalol hydrochloride [51-02-5]; Down 200; 15uM; MCF7; HT_HG-U133A | 7.73e-05 | 194 | 120 | 7 | 7322_DN | |
| Drug | 5666823; Down 200; 100uM; MCF7; HG-U133A | 7.98e-05 | 195 | 120 | 7 | 609_DN | |
| Drug | Famotidine [76824-35-6]; Up 200; 11.8uM; PC3; HG-U133A | 7.98e-05 | 195 | 120 | 7 | 1946_UP | |
| Drug | PF-00539758-00 [351321-34-1]; Up 200; 10uM; PC3; HT_HG-U133A | 7.98e-05 | 195 | 120 | 7 | 6379_UP | |
| Drug | Diethylstilbestrol [56-53-1]; Down 200; 15uM; MCF7; HT_HG-U133A | 7.98e-05 | 195 | 120 | 7 | 4369_DN | |
| Drug | Ozagrel hydrochloride [78712-43-3]; Down 200; 15.2uM; MCF7; HT_HG-U133A | 7.98e-05 | 195 | 120 | 7 | 3503_DN | |
| Drug | Pergolide mesylate [66104-23-2]; Up 200; 9.8uM; PC3; HT_HG-U133A | 8.24e-05 | 196 | 120 | 7 | 7271_UP | |
| Drug | Benfotiamine [22457-89-2]; Down 200; 8.6uM; MCF7; HT_HG-U133A | 8.51e-05 | 197 | 120 | 7 | 3837_DN | |
| Drug | Ioversol [87771-40-2]; Down 200; 5uM; MCF7; HT_HG-U133A | 8.51e-05 | 197 | 120 | 7 | 3365_DN | |
| Drug | Spiramycin [8025-81-8]; Down 200; 4.8uM; HL60; HT_HG-U133A | 8.51e-05 | 197 | 120 | 7 | 2558_DN | |
| Drug | Clopamide [636-54-4]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 8.51e-05 | 197 | 120 | 7 | 5402_DN | |
| Drug | Reserpinic acid hydrochloride; Down 200; 9.2uM; MCF7; HT_HG-U133A | 8.78e-05 | 198 | 120 | 7 | 7323_DN | |
| Drug | Alprenolol hydrochloride [13707-88-5]; Down 200; 14uM; HL60; HG-U133A | 8.78e-05 | 198 | 120 | 7 | 1571_DN | |
| Drug | Apramycin [37321-09-8]; Down 200; 7.4uM; MCF7; HT_HG-U133A | 8.78e-05 | 198 | 120 | 7 | 7334_DN | |
| Drug | Cyclopenthiazide [742-20-1]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 8.78e-05 | 198 | 120 | 7 | 7325_UP | |
| Drug | Troleandomycin [2751-09-9]; Down 200; 5uM; HL60; HG-U133A | 9.06e-05 | 199 | 120 | 7 | 1965_DN | |
| Drug | Disopyramide [3737-09-5]; Down 200; 11.8uM; HL60; HT_HG-U133A | 9.06e-05 | 199 | 120 | 7 | 2408_DN | |
| Drug | Foliosidine [2520-38-9]; Up 200; 13uM; PC3; HT_HG-U133A | 9.06e-05 | 199 | 120 | 7 | 4295_UP | |
| Drug | Parbendazole [14255-87-9]; Down 200; 16.2uM; MCF7; HT_HG-U133A | 9.06e-05 | 199 | 120 | 7 | 4357_DN | |
| Drug | Eucatropine hydrochloride [536-93-6]; Down 200; 12.2uM; PC3; HT_HG-U133A | 9.06e-05 | 199 | 120 | 7 | 3759_DN | |
| Drug | Clch2cosg | 1.10e-04 | 18 | 120 | 3 | CID000163913 | |
| Drug | C14791 | 1.10e-04 | 18 | 120 | 3 | CID011954044 | |
| Drug | C14793 | 1.10e-04 | 18 | 120 | 3 | CID011954046 | |
| Drug | C14803 | 1.10e-04 | 18 | 120 | 3 | CID011954054 | |
| Drug | C14805 | 1.10e-04 | 18 | 120 | 3 | CID011954056 | |
| Drug | C14804 | 1.10e-04 | 18 | 120 | 3 | CID011954055 | |
| Drug | C14806 | 1.10e-04 | 18 | 120 | 3 | CID011954057 | |
| Drug | C14848 | 1.10e-04 | 18 | 120 | 3 | CID011954067 | |
| Drug | C14856 | 1.10e-04 | 18 | 120 | 3 | CID011954069 | |
| Drug | C14855 | 1.10e-04 | 18 | 120 | 3 | CID011954068 | |
| Drug | S-(2,2-dichloro-1-hydroxy)ethylglutathione | 1.10e-04 | 18 | 120 | 3 | CID011954070 | |
| Drug | AC1L4MYY | 1.10e-04 | 18 | 120 | 3 | CID000188517 | |
| Drug | 2-(S-glutathionyl) acetyl glutathione | 1.52e-04 | 20 | 120 | 3 | CID011954072 | |
| Drug | C14865 | 1.52e-04 | 20 | 120 | 3 | CID011954073 | |
| Drug | 5-S-glutathionyl-alpha-methyldopa | 1.64e-04 | 4 | 120 | 2 | ctd:C086396 | |
| Drug | 5-S-glutathionyldopamine | 1.64e-04 | 4 | 120 | 2 | ctd:C086394 | |
| Drug | benzotriazole | 1.64e-04 | 4 | 120 | 2 | ctd:C012771 | |
| Drug | AC1L4TYZ | 1.64e-04 | 4 | 120 | 2 | CID000192227 | |
| Drug | cafestol | 1.77e-04 | 21 | 120 | 3 | ctd:C053400 | |
| Drug | AA-GSH | 2.34e-04 | 23 | 120 | 3 | CID000083998 | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.44e-04 | 165 | 120 | 6 | 2835_DN | |
| Drug | S-(formylmethyl)glutathione | 2.67e-04 | 24 | 120 | 3 | CID011954074 | |
| Drug | prostaglandin A2 | 2.73e-04 | 5 | 120 | 2 | ctd:C100008 | |
| Drug | Benzoxazoles | 2.73e-04 | 5 | 120 | 2 | ctd:D001583 | |
| Drug | Selenium Compounds | 2.73e-04 | 5 | 120 | 2 | ctd:D018036 | |
| Drug | Gonadotropins | 2.73e-04 | 5 | 120 | 2 | ctd:D006062 | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.78e-04 | 169 | 120 | 6 | 5572_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.87e-04 | 170 | 120 | 6 | 5417_DN | |
| Drug | NAPQI | 3.04e-04 | 61 | 120 | 4 | CID000039763 | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 3.06e-04 | 172 | 120 | 6 | 2330_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 3.06e-04 | 172 | 120 | 6 | 2794_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 3.25e-04 | 174 | 120 | 6 | 3462_DN | |
| Drug | HC toxin from Helminthosporium carbonum; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 3.25e-04 | 174 | 120 | 6 | 909_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 3.25e-04 | 174 | 120 | 6 | 5945_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 3.35e-04 | 175 | 120 | 6 | 7236_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 3.35e-04 | 175 | 120 | 6 | 1014_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 3.46e-04 | 176 | 120 | 6 | 6932_DN | |
| Drug | SAHA; Down 200; 10uM; MCF7; HT_HG-U133A | 3.46e-04 | 176 | 120 | 6 | 6980_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 3.46e-04 | 176 | 120 | 6 | 5976_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; HL60; HT_HG-U133A | 3.67e-04 | 178 | 120 | 6 | 6193_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 3.67e-04 | 178 | 120 | 6 | 1471_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 3.67e-04 | 178 | 120 | 6 | 1672_DN | |
| Drug | trichostatin A; Down 200; 0.1uM; MCF7; HG-U133A | 3.78e-04 | 179 | 120 | 6 | 331_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 4.01e-04 | 181 | 120 | 6 | 6951_DN | |
| Drug | 2-allylphenol | 4.08e-04 | 6 | 120 | 2 | ctd:C099328 | |
| Drug | 1,2-dichloro-4-nitrobenzene | 4.08e-04 | 6 | 120 | 2 | ctd:C028328 | |
| Drug | 1-cyano-2-hydroxy-3-butene | 4.08e-04 | 6 | 120 | 2 | ctd:C055903 | |
| Drug | 2 Ig | 4.08e-04 | 6 | 120 | 2 | CID006914626 | |
| Drug | isomethyleugenol | 4.08e-04 | 6 | 120 | 2 | ctd:C031050 | |
| Drug | 17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 4.13e-04 | 182 | 120 | 6 | 947_DN | |
| Drug | AC1Q608X | 4.25e-04 | 28 | 120 | 3 | CID000128466 | |
| Drug | AC1L33DC | 4.25e-04 | 28 | 120 | 3 | CID000133757 | |
| Drug | Ellipticine [519-23-3]; Up 200; 16.2uM; MCF7; HT_HG-U133A | 4.38e-04 | 184 | 120 | 6 | 2758_UP | |
| Drug | CPG-oligonucleotide | 4.38e-04 | 184 | 120 | 6 | ctd:C408982 | |
| Drug | (1-[(4-Chlorophenyl)phenyl-methyl]-4-methylpiperazine) [1620-21-9]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 4.50e-04 | 185 | 120 | 6 | 3893_UP | |
| Drug | torcetrapib | 4.67e-04 | 342 | 120 | 8 | ctd:C483909 | |
| Drug | 2-BHA | 4.72e-04 | 29 | 120 | 3 | CID000006932 | |
| Drug | ethanol | CACNA1E MYLK SYNM AOX1 REV3L GSTA1 GSTA2 GAL GSTA5 EIF2AK3 ADAT1 EPB41 CA5A | 4.77e-04 | 837 | 120 | 13 | CID000000702 |
| Drug | LY 294002; Down 200; 10uM; HL60; HT_HG-U133A | 4.90e-04 | 188 | 120 | 6 | 1177_DN | |
| Drug | Clioquinol [130-26-7]; Up 200; 13uM; HL60; HT_HG-U133A | 5.04e-04 | 189 | 120 | 6 | 3084_UP | |
| Drug | Ampyrone [83-07-8]; Down 200; 19.6uM; PC3; HT_HG-U133A | 5.19e-04 | 190 | 120 | 6 | 4507_DN | |
| Drug | Methotrexate [59-05-2]; Down 200; 8.8uM; PC3; HT_HG-U133A | 5.19e-04 | 190 | 120 | 6 | 6318_DN | |
| Disease | body surface area | 2.16e-04 | 643 | 115 | 10 | EFO_0022196 | |
| Disease | depressive symptom measurement | 2.72e-04 | 426 | 115 | 8 | EFO_0007006 | |
| Disease | neuroimaging measurement | SOX5 CHAF1A TNRC6B REV3L ZHX2 SYNJ1 NFIX AKAP10 KIF18B TNS1 PCDH7 EIF2AK3 WWC1 | 2.76e-04 | 1069 | 115 | 13 | EFO_0004346 |
| Disease | nemaline myopathy (implicated_via_orthology) | 4.15e-04 | 8 | 115 | 2 | DOID:3191 (implicated_via_orthology) | |
| Disease | hair colour measurement | 6.95e-04 | 615 | 115 | 9 | EFO_0007822 | |
| Disease | Charcot-Marie-Tooth Disease | 9.69e-04 | 12 | 115 | 2 | C0007959 | |
| Disease | age at menopause | 1.21e-03 | 302 | 115 | 6 | EFO_0004704 | |
| Disease | cortical thickness | SOX5 KLHL24 CHAF1A TNRC6B MALRD1 UBTF NFIX KMT2A AKAP10 DIAPH3 TNS1 PCDH7 | 1.36e-03 | 1113 | 115 | 12 | EFO_0004840 |
| Disease | glucose homeostasis measurement, glucose effectiveness measurement | 1.53e-03 | 15 | 115 | 2 | EFO_0006833, EFO_0006896 | |
| Disease | 1,3,7-trimethylurate measurement | 1.53e-03 | 15 | 115 | 2 | EFO_0021172 | |
| Disease | teratocarcinoma-derived growth factor 1 measurement | 1.74e-03 | 16 | 115 | 2 | EFO_0008297 | |
| Disease | verbal-numerical reasoning measurement | 1.75e-03 | 131 | 115 | 4 | EFO_0008394 | |
| Disease | Myeloid Leukemia | 2.21e-03 | 18 | 115 | 2 | C0023470 | |
| Disease | Leukemia, Monocytic, Chronic | 2.21e-03 | 18 | 115 | 2 | C0023466 | |
| Disease | stroke, major depressive disorder | 2.47e-03 | 19 | 115 | 2 | EFO_0000712, MONDO_0002009 | |
| Disease | type 1 diabetes mellitus (biomarker_via_orthology) | 2.47e-03 | 19 | 115 | 2 | DOID:9744 (biomarker_via_orthology) | |
| Disease | cognitive function measurement, self reported educational attainment | 2.73e-03 | 355 | 115 | 6 | EFO_0004784, EFO_0008354 | |
| Disease | amblyopia | 3.31e-03 | 22 | 115 | 2 | MONDO_0001020 | |
| Disease | non-melanoma skin carcinoma | 3.87e-03 | 265 | 115 | 5 | EFO_0009260 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PSKKPMSRGDRFSED | 696 | P23470 | |
| SELKKNFMESVPEPR | 686 | P11171 | |
| APAFPRKKDEADMSN | 176 | Q96KC9 | |
| DVKPTPDFVEKLREM | 61 | Q8NEF3 | |
| DKTPMSRRLEKTEPY | 116 | Q15878 | |
| DAPSVKIRRMDPFAT | 691 | Q9NZJ5 | |
| GEDSPAPKRMKLDSR | 271 | Q9C0J9 | |
| SEPEPDVRKSKGSMF | 601 | O43572 | |
| ATRTFEMRKKPPPEE | 211 | Q96Q83 | |
| MANSTGKAPPDERRK | 1 | Q68CP9 | |
| PEPKSRFAMLDDVKI | 31 | Q9Y5C1 | |
| ADPSSKAAMRRKDSP | 526 | A6QL64 | |
| KAMLEPENTPFKSRD | 2591 | Q8TDJ6 | |
| ATAMDCKDRPAFPVK | 16 | Q13111 | |
| PPEDLHDKFVTKMSR | 941 | Q9NSV4 | |
| EFSPEDSPSVRMEAK | 211 | Q6ZUJ8 | |
| DMKAKVPSPRFGIET | 896 | Q96MT7 | |
| CEDPDSPVTKKMRLE | 186 | Q9BUB4 | |
| EDKFTKMIPRDEPGS | 1316 | Q06278 | |
| PMEKRIAADFDPRAS | 636 | Q6UXK2 | |
| SMKDKPRSPFSKIRD | 181 | Q9BXF6 | |
| PKSPDEMRKVFIDRA | 411 | O75311 | |
| PPMDEKSLEEARKIF | 206 | P08263 | |
| PPMDEKSLEEARKIF | 206 | Q7RTV2 | |
| PFARPLDMERKKSEH | 416 | Q92932 | |
| RDSLESSPVEPKMKA | 2466 | Q01484 | |
| ATGKDMEERKRKAPP | 131 | Q9BZE7 | |
| PASENTKAPEMKSRR | 1191 | Q15746 | |
| KRPKSIDDSEMESPV | 276 | Q14938 | |
| MPPAEKASRIRAAEK | 1011 | Q14676 | |
| ERASPIKMDLAPSKD | 381 | P27816 | |
| TRPKKMEKEPAARGT | 61 | Q96MG2 | |
| SCKEPPEVQSFREKM | 1081 | Q8IX03 | |
| KSRMPEAREPPEKTN | 496 | Q0VAK6 | |
| MPLFFRKRKPSEEAR | 1 | Q6UWE0 | |
| MPVKKSPRRSSSDEQ | 546 | Q9NPH3 | |
| RPSKSMDKKEDRGPE | 216 | Q9C098 | |
| PPMDEKSLEESRKIF | 206 | P09210 | |
| PSAIPDDTFMDSRKA | 776 | A7E2Y1 | |
| PDLIMRARKTFPSKE | 181 | Q32ZL2 | |
| MARDRGQPPKTDKAT | 386 | O60245 | |
| SDDEIPIRKKERNPM | 966 | Q1MSJ5 | |
| APVDRKAKASAMPDS | 51 | O75081 | |
| EADSPMAPKRGTKRQ | 636 | Q86Y91 | |
| MPPLEDDDKFTETKR | 716 | Q6ZMV5 | |
| EERTMIDPTSKEDPK | 71 | Q9HBI1 | |
| KAFSMDEPVAAKRPV | 341 | Q9NQ84 | |
| MEEFTPPSREDRNAK | 531 | O94913 | |
| PEEDTERTERKPMVK | 11 | Q9NQV7 | |
| EETQKTDPAMEPRFK | 101 | Q7L5A8 | |
| MRTKAREIPAFESTP | 291 | Q5VYJ5 | |
| PEIKHKDARAAMRPF | 201 | P35218 | |
| KDARAAMRPFDPSTL | 206 | P35218 | |
| EVMESSAKIKREPPE | 326 | Q7Z6J6 | |
| KEMFSFVVDDARKPP | 171 | B1AJZ9 | |
| VRDSPATKRKVFEMD | 16 | Q6TFL4 | |
| DRPMKATAFPAEVKD | 1561 | Q5JSL3 | |
| VTKKNREDMTAPPRE | 4356 | Q9UFH2 | |
| TSKRELRPEDDMKPG | 61 | P22466 | |
| LRPEDDMKPGSFDRS | 66 | P22466 | |
| PDFKEFVKRLAMDPR | 1351 | Q15811 | |
| KAPKQARKERPADMD | 11 | Q9BQM9 | |
| KASEAEMVSAIKPPR | 126 | P41182 | |
| TMTVRKAEKVDPSEP | 111 | Q8NA82 | |
| ASMEASPKAKARDAP | 456 | Q8IWC1 | |
| DPPRTDRILMKATAF | 276 | Q53TQ3 | |
| SKPERPMKFLREHFE | 41 | P31321 | |
| RKRAVFPDDMPTLSA | 1081 | Q03164 | |
| MLRRKPSNASEKEPT | 1 | O75995 | |
| EAMRLPKNTPEEKDR | 421 | O95954 | |
| SDSPSMKKESELPRR | 366 | Q9BY77 | |
| AKRSESMEPKVFRDP | 111 | Q5THK1 | |
| EEDPPAKRKCIFMSE | 481 | O75928 | |
| ADMPKSPFKRKRTTN | 531 | Q6PCB5 | |
| NRPETIRTKPEEKMF | 511 | O15061 | |
| REMEAPKSPGTTRKD | 1156 | O43426 | |
| RKSEAKQMPRAAPAT | 306 | Q15345 | |
| RSKPLMRSEPEKNTE | 1301 | Q5UIP0 | |
| ITDISDFKRKMPDLP | 341 | Q16773 | |
| RRPDSSAMEVEPKKL | 76 | Q9NQV5 | |
| PEGDTERTERKPMVK | 11 | Q9NQW5 | |
| RASSKFKDPPRIMQS | 16 | Q9P2F8 | |
| SPFKDLMTVPESRDE | 911 | Q7Z333 | |
| KRKRSEKPMAEDPVR | 1161 | Q7Z333 | |
| DMADTPCELAKRDPK | 1001 | Q9UPS6 | |
| SMIPKARESFLEKRP | 351 | Q8IX21 | |
| RANEKLRKEMAAAPP | 81 | Q8N5I9 | |
| KNVMEDPFPRKSSTI | 661 | Q86YF9 | |
| PFSVNKMLPREKEAS | 181 | Q01968 | |
| EPREMVRPKKVCFSE | 151 | Q9H0A9 | |
| RVPAKRKLEMEDYPS | 336 | Q9NY61 | |
| DSAPEDPTSPKRKMR | 1401 | Q96RK0 | |
| ISPSKRKFSMEPGDE | 51 | Q14135 | |
| KKIMPDDPERFDSSV | 351 | Q86WT6 | |
| MAPKFPDSVEELRAA | 1 | Q15785 | |
| VDDPPDKEDMRSSFR | 146 | Q9HCE3 | |
| DDMGSEPKRTLPFRK | 1466 | Q86UP3 | |
| LDMSNFKPERVKPRS | 1481 | O60673 | |
| KVAMDLKDPNRPRFT | 281 | Q5EBL4 | |
| PREERKSPEDKKSMI | 1181 | Q9BYB0 | |
| FDTMDIDLPPSKNRR | 1191 | Q8N3U4 | |
| FLKPDERAPTEMAKA | 876 | Q9H7N4 | |
| VPREERKKFPLSEGM | 196 | Q5T4T6 | |
| SDPKQLAEFARMKPR | 271 | P25490 | |
| ARSAMDDTGTKRPPK | 1761 | P22105 | |
| SMPDNSPETRAKVKF | 1441 | Q9HBL0 | |
| IAMKTDPRPDAATIK | 1096 | P29144 | |
| KEEPLMSAFASEPRK | 291 | Q9BWH6 | |
| RPTPDQLMKDKVFSE | 261 | Q8TEA7 | |
| KEPNPASMRVKDAAE | 886 | Q86X10 | |
| PPARKSSEELDMDKV | 71 | Q6ZNC4 | |
| DAVARKATKPMAESP | 706 | Q9Y6X8 | |
| LPKMEVRAEEPKEAT | 71 | A8MUI8 | |
| LPKMEVRAEEPKEAT | 71 | A8MUA0 | |
| DPTPTMRDVNKKFSV | 256 | O75436 | |
| KESPGDLTRSPEMDK | 231 | O43149 | |
| DLPQEFERMSSKRPA | 6 | P35711 | |
| ARLPKMEVRAEEPKE | 106 | Q5PR19 | |
| KLDPVFDSPRMSRRS | 41 | O94901 | |
| DSGMPKERFTAERPN | 76 | A0A087X0K7 | |
| KPKRPVSAMFIFSEE | 406 | P17480 | |
| KLSDPPKAEAIRDMV | 281 | Q9NRG4 | |
| EKEFEKVPLFMSRAP | 36 | O95801 | |
| EDMQPKDPAALRSSR | 221 | A6NL46 | |
| SPPATKRDSEVKMDF | 216 | Q9UGI0 | |
| MRKDRSGFRPPNSKD | 1111 | Q9UPQ9 | |
| TPRKERRPSMFEKEA | 26 | Q8IZS6 | |
| PDRNKFTSIPDAMDI | 2451 | P20929 |